A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer

Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological and clinical factors are used to select patients f...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Havjin Jacob, Luka Stanisavljevic, Kristian Eeg Storli, Kjersti E. Hestetun, Olav Dahl, Mette P. Myklebust
Format: article
Langue:EN
Publié: Nature Portfolio 2018
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/9dd3caffa57b43dc8719f849893eb89b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!